ST. LOUIS, July 13 /PRNewswire/ -- Dr. Gerlof Homan, president and CEO of Senetek PLC (NASDAQ: SNTKY), announced the successful completion of a $6.8 million equity private placement.
Dr. Homan stated that these funds are sufficient to commercialize Senetek's Male Sexual Dysfunction (MSD) product and their proprietary auto-injector. Limited production of the product has just begun for the purpose of clinical trials.
Senetek is currently in advanced discussions with several large pharmaceutical companies concerning the licensing of its MSD product and auto-injector. Dr. Homan stated that significant progress has been made in these negotiations.
-0- 7/13/93
/CONTACT: Dennis Nebbe of Senetek PLC, 800-869-1696/
(SNTKY)

CO: Senetek PLC ST: Missouri IN: MTC SU:

BR-BN -- AT003 -- 0844 07/13/93 11:25 EDT

COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.